MTA2 and head and neck cancer: Indeed, to date, HBD-3 has only been shown to inhibit tumour cell migration by suppressing vascular endothelial growth factor in head and neck cancer cells [37] or down-regulating MTA2 (metastasis-associated 1 family, member 2) expression of colon cancer cells [38].